INF-free sofosbuvir-based treatment of post-transplant hepatitis C relapse – a Swedish real life experience-Reference-Cited by-同舟云学术

INF-free sofosbuvir-based treatment of post-transplant hepatitis C relapse – a Swedish real life experience

Published:2017-02-13 Issue:5 Volume:52 Page:585-588
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Maria Castedal¹,Michael Segenmark²,Susanne Cederberg²,Catarina Skoglund¹,Ola Weiland²

Affiliation:

1. The Transplant Institute, Sahlgrenska University Hospital, Institution of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden;

2. Department of Medicine, Division of Infectious Diseases, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2017.1283439

Reference20 articles.

1. Adam R, Karam V, Delvart V, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012;57:675–688.

2. Treating hepatitis C infection in liver transplant recipients

3. Liver Transplantation for HCV Cirrhosis at Karolinska University Hospital Huddinge, Stockholm

4. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C

5. The association between hepatitis C infection and survival after orthotopic liver transplantation

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapy with Direct-Acting Antiviral Agents in Transplanted Patients with HCV Recurrence: A Retrospective Analysis;Hepatitis Monthly;2019-07-24

2. Sofosbuvir-based antiviral therapy in patients with recurrent HCV infection after liver transplant: A real-life experience;Annals of Hepatology;2019-05

Efficacy of direct-acting antiviral therapy for hepatitis C viral infection. Real-life experience in Bahrain

;Hepatic Medicine: Evidence and Research;2019-05

4. Impact of direct‐acting antivirals for hepatitis C virus therapy on tacrolimus dosing in liver transplant recipients;Transplant Infectious Disease;2019-04

5. No need to discontinue hepatitis C virus therapy at the time of liver transplantation;PLOS ONE;2019-02-22